Sign In
Buy CERE
$44.96
+0 (+0%)
At Close: Oct 30, 2024
Cerevel Therapeutics to Present at Upcoming Investor Conferences
06:30am, Friday, 11'th Nov 2022
CAMBRIDGE, Mass., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that me
Why Cerevel Therapeutics (CERE) Might Surprise This Earnings Season
11:38am, Monday, 07'th Nov 2022
Cerevel Therapeutics (CERE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Cerevel Therapeutics to Report Third Quarter 2022 Financial Results and Pipeline Update on Tuesday, November 8, 2022
06:30am, Wednesday, 19'th Oct 2022
CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced
Cerevel Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06:30am, Tuesday, 06'th Sep 2022
CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that m
Cerevel Therapeutics Stock Is Falling: Here's Why
03:16pm, Tuesday, 16'th Aug 2022
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower by 7.1% to $32.00 during Tuesday's trading session after the company priced its underwritten common stock offering of 7.25 mil
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q2 2022 Results - Earnings Call Transcript
02:30pm, Monday, 01'st Aug 2022
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q2 2022 Earnings Conference Call August 1, 2022 8:00 AM ET Company Participants Matt Calistri - Vice President of Corporate Strategy and Investor Rel
Cerevel Therapeutics to Report Second Quarter 2022 Financial Results and Pipeline Update on Monday, August 1, 2022
05:00pm, Monday, 25'th Jul 2022
CAMBRIDGE, Mass., July 25, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced
Cerevel Therapeutics to Present at the Jefferies Healthcare Conference
06:30am, Wednesday, 25'th May 2022
CAMBRIDGE, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that c
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q1 2022 Results - Earnings Call Transcript
03:59pm, Saturday, 14'th May 2022
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Matt Calistri - Vice President of Corporate Strategy and Investor Relat
Cerevel Therapeutics to Present at the Stifel 4th Annual CNS Day Event
06:30am, Monday, 21'st Mar 2022
CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced that
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q4 2021 Results - Earnings Call Transcript
12:15pm, Tuesday, 01'st Mar 2022
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q4 2021 Results - Earnings Call Transcript
3 Stocks Beating the S&P 500
12:57pm, Friday, 04'th Feb 2022
Shareholders of Cerevel Therapeutics Holdings Inc ( CERE , Financial), Rexford Industrial Realty Inc. ( REXR , Financial), and Korn Ferry ( KFY , Financial) saw the value of their shares increase sign
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q3 2021 Results - Earnings Call Transcript
10:58am, Wednesday, 10'th Nov 2021
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q3 2021 Results - Earnings Call Transcript
New York, New York--(Newsfile Corp. - September 15, 2021) - Levi & Korsinsky announces it has commenced an investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) concerning possible breac
3 Biotech Stocks That Soared to New Heights Last Week
06:21am, Sunday, 05'th Sep 2021
Find out what these industry favorites are doing to impress investors.
